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OBJECTIVE: To report a case of bilateral giant renal angiomyolipoma associated with tuberous sclerosis, with
successful treatment, and to review the literature concerning angiomyolipoma treatment.
CASE REPORT: Patient with tuberous sclerosis and angiomyolipoma diagnosed by ultrasonography during her
pregnancy. At that time, the angiomyolipoma on the right side was 9 cm in diameter. Conservative management was selected
during her pregnancy. The patient returned 7 years later, with a 24.7 x 19.2 x 10.7 cm tumor on the right side and another of
13 x 11.5 x 6.5 cm on the left side, in addition to multiple small angiomyolipomas. A nephron-sparing surgery with tumoral
enucleation was performed on the right side, and after 3 months, the tumor on the left side was removed. Renal function in
the post-operative period was preserved, and contrast medium progression was uniform and adequate in both kidneys.
CONCLUSION: We conclude that an angiomyolipoma larger than 4 cm should be removed surgically, since they have
a greater growth rate and pose a risk of hemorrhage. Resection of smaller tumors is safe and has decreased morbidity. Tumoral
enucleation is an effective treatment method that preserves kidney function.
DESCRIPTORS: Angiomyolipoma. Tuberous sclerosis. Hepatic lipoma. Nephron-sparing surgery. Therapeutic.
INTRODUCTION
Renal angiomyolipoma is a benign
tumor comprised of 3 different types
of tissue: fatty, smooth muscle, and
vascular. It is estimated to occur in
0.3% of the population and comprises
3% of the solid renal masses1,2. It af-
fects 2 distinctive populations: the
bearers and the non-bearers of tuber-
ous sclerosis. Tuberous sclerosis is a
dominant autosomal congenital dis-
ease, having an estimated frequency in
the western society of 1:10.000. It  re-
sults from alterations in the 9q34 or
16p13.3 chromosome and is normally
characterized by a classic triad of men-
tal retardation, epilepsy, and seba-
ceous adenomas3-5. Angiomyolipoma
associated with tuberous sclerosis oc-
curs with greatest frequency between
the second and third decade while in
its isolated form. It primarily affects
women between the fourth and seventh
decade of life6. The most common
signs and symptoms are abdominal
pain, palpable abdominal mass,
hematuria and other consequences of
intra-tumoral hemorrhage7. The latter
occurs in approximate 25% of the pa-
tients; in 10% of them, it can lead to
hypovolemic shock when in the acute
phase8,9. The symptoms and complica-
tions of angiomyolipoma are related to
its size and rapidity of growth. Lesions
greater than 4 cm in size indicate a
greater risk of complication, such as
hemorrhage. According to the litera-
ture, management depends on its size,
which indicates the best treatment to
be given10.
Fifty-four cases of giant renal
angiomyolipoma were found to be re-
ported in the literature, with only 11
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of them being larger than that in the
present case. We have found only 1
case of similar association of renal
angiomyolipoma, tuberous sclerosis,
and hepatic lipoma11. We undertook
this bibliographic research using the
PUBMED database and the following
keywords: renal angiomyolipoma and
tuberous sclerosis, giant renal angio-
myolipoma, renal angiomyolipoma,
tuberous sclerosis and lipoma,
angiomyolipoma, and hepatic lipoma.
We present 1 case of giant (> 12 cm)
bilateral renal angiomyolipoma asso-
ciated with hepatic lipoma that was di-
agnosed in a pregnant woman with tu-
berous sclerosis.
CASE  REPORT
A female patient, 34 years old, who
had bearded tuberous sclerosis and had
experienced convulsive crises since
she was 8 years old, presented during
pregnancy (20 weeks) reporting left
lumbar pain. On physical examination,
she presented no abnormalities, but
the abdominal sonography showed a
renal mass of 9 cm diameter on the
right. Magnetic resonance imaging
confirmed the presence of a tumor of
the dimensions given above in her
right kidney, suggesting a diagnosis of
renal angiomyolipoma. It was decided
to leave her under observation during
pregnancy and to resolve the case af-
ter delivery. The patient did not return
for follow up after the birth, but came
back, asymptomatic, to the clinic 7
years later, reporting that 3 months
previously, a right abdominal mass of
large proportions had been discovered
during a physical exam. She also said
she had lost 8 kg during the 3 months.
She denied any family history of tu-
berous sclerosis. We observed around
the nose multiple sebaceous adenomas
and warts under the toe nails. Hy-
pochromic patches (café-au lait) were
noted on her trunk, and a mass was
present on her right flank. On physi-
cal examination, there was a hepato-
megaly, and the tumoral mass was pal-
pable in the right flank and iliac re-
gion, extending to the mesogastrium
and going beyond the midline; it had
a smooth surface of solid consistence,
of low mobility, and clear limits.
Abdominal sonography showed a
solid mass of 24.7 x 19.2 x 10.7 cm in
size and of 2638 cm3 in volume,
though it was impossible to identify
its origin. Computed tomography
showed topical kidneys with non-spe-
cific hypoattenuated cortical nodular
images of less than 1 cm, possibly cor-
responding to cysts or angiomyo-
lipoma as well as hypo-attenuant solid
nodules with very high fat content.
Some of the tumors of considerable
size with evident blood vessels in the
interiors were pushing the intestine
forward. The largest at the lower pole
of the right kidney measured 20 x 15
x 16 cm extending as far as the pelvic
region (Fig. 1). The presence of he-
patic lipoma was also demonstrated;
there were 3 rounded hypoattenuated
images in the right lobe, less than 1 cm
in size, which could represent small
cysts or lipomas. Further, there was an-
other hypoattenuated, cleared, delim-
ited nodule of fat density in segment
III.
Kidney function was normal, and
the urine analyses showed discrete
proteinuria (0.34 g/24h). Radionuclide
renography with DMSA showed bilat-
eral depressed renal tubular function,
primarily in the right kidney, signs
suggestive of sequels of pyelonephri-
tis of the left kidney and bilateral dila-
tation of the collecting system.
The patient underwent medial lon-
gitudinal laparotomy and enucleation
of the tumors of the right kidney, pre-
serving the renal tissue as much as pos-
sible. The largest tumor in the inferior
pole and small tumoral masses were
withdrawn, weighing altogether 2020
g and measuring 23.0 x 21.0 x 11.5
cm. There was no intention of com-
pletely withdrawing all small intra-
renal tumors, because this might dam-
age the renal function. A further he-
patic lipoma in segment III of 1.5 cm
was removed. The pathology exami-
nation revealed angiomyolipoma with
predominance of fat component and
hepatic lipoma. The renal tumor re-
acted positively to HMB-45, an impor-
tant angiomyolipoma marker, but the
hepatic lipoma didn’t. After 3 months,
the patient underwent another opera-
Figure 1 - Computed tomography before surgery: A giant angiomyolipoma (23 x 21 x 11.5
cm) in the right kidney and another (13 x 9.5 x 5.5 cm) in the left kidney.
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tion for the enucleation of the tumors
on the left kidney, the technique be-
ing repeated and the renal tissue pre-
served. The various irregular tumor
fragments weighed a total of 475 g and
the largest of the fragments measured
13.0 x 9.5 x 5.5 cm.
After surgery, renal function main-
tained normal. Computed tomography
revealed good renal function and mul-
tiple small solid nodules on both kid-
neys. After 2 years, computed tomog-
raphy was repeated and revealed pre-
served renal function and nodules of
the same size of the last exam (Fig. 2).
DISCUSSION
Tuberous sclerosis is a dominant
autosomal congenital disease that is
characterized clinically by the classi-
cal triad of mental retardation, epi-
lepsy, and sebaceous adenoma12. Char-
acteristically, tuberous sclerosis occurs
in the brain, where whitish nodules are
found in the distorted cortical cytoar-
chitecture, with deformed, bizarre neu-
rons that are frequently enlarged. Re-
nal angiomyolipomas, cardiac rhab-
domyomas, and pancreatic cysts may
be associated with the tuberous scle-
rosis13. From 40% to 80% of the bear-
ers of tuberous sclerosis present with
renal angiomyolipoma with multiple
bilateral asymptomatic tumors, which
may be associated with cysts and more
rarely renal carcinoma6, 12. In those pa-
tients with angiomyolipoma without
tuberous sclerosis, the tumor is gener-
ally single, larger, and assympto-
matic6,8,14. The angiomyolipoma may
affect the perirenal fat and local lym-
phatic vessels, and the presence of
tumors in extra renal sites is considered
multicentric and not metastatic. An-
giomyolipoma may occur in the
lungs, liver, Fallopian tubes, vagina,
spermatic cord, penis, or nasal cavi-
ties14. The association of angiomyo-
lipoma and hepatic lipoma is rarely
observed in patients with tuberous
sclerosis11.
Although angiomyolipoma is
comprised of 3 distinct groups of tis-
sue, pleomorphism and aneuploid mi-
totic figures may occur in some cases.
Electronic microscopy not infre-
quently reveals muscular cells with li-
pid content as if simulating a cell in-
termediate between smooth muscular
and fat cell. These findings corrobo-
rate the hypothesis that the different
types of tissue originate from one stem
cell 15. Because of the presence of
multinucleated giant cells, it may be
difficult to distinguish the tumor from
liposarcoma, malignant fibrous histio-
cytoma, leiomyosarcoma, or sarco-
matoid carcinoma. This difficulty em-
phasizes the importance of HMB-45
immunoreaction, because a mono-
clonal antibody reacts specifically
with premelanosomes in the smooth
muscle cells. No other benign or ma-
lignant renal tumors show staining
with HMB-45. This confirmation is
important for the correct definition of
the nature of the tumor and the most
appropriate procedures for the pa-
tient16, 17.
The natural history of angiomyo-
lipoma is not fully known; however,
some authors have presented some im-
portant observations. Steiner and col-
leagues studied 35 patients with a to-
tal of 48 lesions, 34 of which were fol-
lowed clinically for 4 years. Of these,
64% presented no change during fol-
low up, and it was found that tumors
initially larger than 4 cm were more
prone to growth. No metachromic le-
sions or renal carcinoma were observed
in this group of patients. It was further
noticed that growth of tumors did not
seem to be due to intra-tumoral bleed-
ing, but rather arose as a result of the
growth of its tissue. The growth may
be slow or rapid, there being no spe-
cific fact known to account for this
rate of growth 18. Ewalt and colleagues
studied the growth of renal lesions in
children suffering from tuberous scle-
rosis and observed that the majority of
the lesions were angiomyolipoma and
had the tendency to grow; they did not
observe any case of regression among
these tumors, in contrast with what oc-
curs with renal cysts. The largest
Figure 2 - Computed tomography 2 years after surgery: Only small intra-parenchymatous
angiomyolipomas less than 1 cm are present in both kidneys, and good kidney preservation is
apparent.
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growth observed in the 60 patients was
4 cm in 1 year (0 to 4cm and in one
other case from 5 to 9 cm). The young-
est patient with angiomyolipoma was
2 years old. It was further observed
that the growth of various lesions in
the same kidney proceeded at differ-
ent rates, the number of lesions and
their rate of growth being progressive
and dependent of age. It was sug-
gested that the loss of the function of
the tumor suppressive gene owing to
a second mutation may explain why
some tumors grow while others main-
tain stable. The hormonal influences
of the steroid receptors in the muscle
cells may explain the differences in
tumor behavior seen during different
periods of life, with greater tumor
growth in post-puberal period and
during pregnancy 12. Other studies add
further that angiomyolipoma in pa-
tients with tuberous sclerosis grow
over time, that tumors greater than 4
cm generally occur post-puberty19, and
that angiomyolipoma has greater like-
lihood of growing in women than in
men because according to hormonal
theory, there are progesterone receptors
in the muscle cells of the tumor 20. In
the literature, there was one report of
6 cases of association of pregnancy
and angiomyolipoma with acute
bleeding, including 2 cases of acute
rupture calling for nephrectomy21.
What may be regarded as certain in the
natural history of the disease is the re-
lationship between size and risk of
complications, with tumors having di-
ameters greater than 4 cm having the
greatest risk of rupture.
As for clinical manifestations, the
main symptom is abdominal pain,
more specifically lumbar pain. Other
possible symptoms and signs are pal-
pable mass, hemorrhage, hematuria,
nausea and vomiting, systemic arterial
hypertension, anemia, fever, shock, re-
nal failure and urinary infection18. In
those patients with lesions smaller
than 4 cm the diagnosis is in the ma-
jority of cases fortuitous during a
physical exam. The symptoms are
more frequent in patients with larger
tumors22; about 25% of patients with
angiomyolipoma present with intense
abdominal pain or with shock due to
intra-tumoral hemorrhage and undergo
emergency nephrectomy8.
At the present time, diagnosis is
made based on abdominal sonography
and computed tomography, by which
the presence of fat cells in the compo-
sition of the tumor is discovered. This
finding is confirmed in the computed
tomography by means of the measure-
ment of image density that should be
less than or equal to – 50 Hounsfield.
Doubt concerning diagnosis persists in
those cases in which there is little fat
content or in the presence of previous
bleeding, which may conceal the pres-
ence of fat cells in the tumor 6,10,23.
The treatment has been fully dis-
cussed in the literature. The decision
regarding treatment methodology is
made primarily based on of the size of
the angiomyolipoma, the symptoms,
the rate of growth, complications, and
the degree of diagnostic certainty re-
garding radiological results. Prior to
1976, 93% of all angiomyolipoma
that were unrelated to tuberous sclero-
sis were treated by total nephrectomy.
More recently, on the basis of
sonography and computed tomogra-
phy, which have created the possibil-
ity of diagnostic certainty, the objec-
tive in the majority of the cases and
as far as possible is conservative treat-
ment. Selective arterial embolization
has shown itself effective in the treat-
ment of acute hemorrhage with or with-
out later surgery or as initial treatment
of the angiomyolipoma8,10. Although
arterial embolization is minimally in-
vasive, it does not preserve renal func-
tion; it only has a temporary effect; it
requires close clinical observation be-
cause of  associated complications;
and as a rule, it is inefficient when used
alone. Regarding surgical treatment,
tumorectomy, partial nephrectomy, or
total nephrectomy may be carried out.
The surgical treatment that preserves
the largest amount of renal tissue is
tumor enucleation, which has been un-
dertaken with excellent results, even
for giant angiomyolipoma (larger than
20 cm), being practically applicable to
patients with tuberous sclerosis who
present multiple and bilateral le-
sions10,24,25. Total nephrectomy should
be used very rarely; it is only justified
in cases of uncontrollable bleeding,
when there is risk to the patient’s life,
in central tumors, in the presence of
extensive necrosis or when there is in-
flammation of the renal tissue, or when
there is a diagnosis of renal carcinoma
in the same kidney. This last scenario
is debatable in the light of recent pro-
posals for surgery for renal carcinoma
with preservation of renal tissue 5,23,26.
More recently, cryotherapy has been
suggested as a therapeutic option and
may be associated with laparoscopy27.
The primary objective of treatment
of angiomyolipoma is the preservation
of renal function, principally in those
cases in which it is associated with tu-
berous sclerosis, in which the lesions
are generally larger, multiple, bilateral,
and recurring. Among therapeutic op-
tions, tumor enucleation makes greater
preservation of the renal tissue possi-
ble, followed by selective arterial em-
bolization and cryotherapy. Emboliza-
tion primarily controls the bleeding in
the acute phase, but may lead to
greater loss of the renal function. Cryo-
therapy is still an undergoing assess-
ment, and additional clinical studies
need to be undertaken to evaluate its
real effectiveness in preserving the re-
nal function. Oesterling and col-
leagues define an algorithm for treat-
ment based on symptoms and the size
of the angiomyolipoma; they pro-
posed follow up, selective emboliza-
tion, or surgical treatment, depending
on the case. Surgery should be con-
servative whenever possible so that
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maximal preservation of renal tissue
(enucleation or partial nephrectomy)
is achieved10.
Steiner and colleagues have pro-
posed changes in Oesterling´s algo-
rithm, thus differentiating the treat-
ment for patients with tuberous scle-
rosis (Fig. 3)18. This differentiation
seems to be preferable to prevent the
tumor from attaining larger dimen-
sions, especially with cases associated
with tuberous sclerosis in which con-
servative surgery is more difficult and
causes greater losses of blood due to
the size of the tumor.
In conclusion, the basis of manage-
ment of angiomyolipoma is the at-
tempted preservation of renal tissue,
which can be effectively achieved with
nephron-sparing surgical procedures
such as tumor enucleation. Under some
conditions, however, it is necessary to
do selective angioembolization, par-
tial nephrectomy, or even total ne-
phrectomy. Especially in patients with
tuberous sclerosis with large bilateral
and multiple tumors, the aim of treat-
ment is the preservation of the great-
est possible degree of efficient renal
function. Therefore, tumoral enuclea-
tion is one of the best choices in these
cases and is perfectly feasible. Smaller
tumors can be excised and submitted
to experimental studies using
laparoscopy or cryotherapy.
Figure 3. Steiner’s algaritm18.
*Consider immediate prophylatic renal arterial embolization or renal sparing surgery.
RESUMO
SCHNEIDER-MONTEIRO ED e col. –
Angiomiolipomas renais gigantes
bilateralmente associados a lipoma
hepático em pacientes com escle-
rose tuberosa. Rev. Hosp. Clín. Fac.
Med. S. Paulo 58(2):103-108,
2003.
OBJETIVO: Relatar um caso de
angiomiolipoma gigante, bilateral, as-
sociado a esclerose tuberosa, tratado
com sucesso e revisar a literatura
concernente ao tratamento do angio-
miolipoma.
RELATO DO CASO: Paciente
portadora de esclerose tuberosa, com
diagnóstico de angiomiolipoma reali-
zado por ultra-sonografia durante ges-
tação. O tumor apresentava 9cm de
diâmetro, à direita. Optou-se por con-
duta conservadora durante a gestação,
e a paciente retornou somente 7 anos
após, com tumor de 24,7 x 19,2 x 10,7
cm à direita e outro à esquerda de 13
x 11,5 x 6,5 cm, além de múltiplos
angiomiolipomas pequenos. Realizada
inicialmente ressecção tumoral à direi-
ta, por enucleação, com preservação
do parênquima renal, e 3 meses após à
esquerda. A função renal pós-operató-
ria se manteve inalterada, e ambos os
rins apresentaram uniformidade e pro-
gressão do contraste adequados.
CONCLUSÃO: Concluímos que os
angiomiolipomas maiores que 4cm de-
vem ser tratados cirurgicamente por-
que têm maior risco de crescimento e
hemorragias. As ressecções de tumores
menores são mais seguras e têm menor
morbidade. A enucleação dos tumores
é forma eficaz de ressecção dos mes-
mos, com preservação de parênquima
renal.
DESCRITORES: Angiomiolipo-
ma. Esclerose tuberosa. Lipoma he-
pático. Enucleação tumoral. Tera-
pêutica.
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